Blood Preparation Market Size By Product (Whole Blood, Blood Components, Blood Derivatives), By Application (Thrombocytosis, Pulmonary Embolism, Renal Impairment, Angina Blood Vessel Complications), By Antithrombotic and Anticoagulants (Platelet Aggregation Inhibitors, Fibrinolytics, Anticoagulants), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, China, Japan, Brazil, Mexico, South Africa), Growth Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2024
Published Date: October 2016 | 168 Pages | Report ID: GMI790 Report Format: PDF
Blood Preparation Market size was more than USD 44.1 billion in 2015 and will exceed USD 64.3 billion at 4.4% CAGR from 2016 to 2024.
U.S. Blood Preparation Market Size, by Product, 2012- 2024 (USD Million)
Rising geriatric population base, technology advancements and increasing patient awareness levels will stimulate global blood preparation market size. Increasing blood disorder prevalence and rising emergency surgeries in hospitals should boost industry growth.
Increased acceptance of advanced blood testing technologies has accelerated accurate diagnosis of hematological disorders. However, chances of transmission of diseases such as, HIV, syphilis, AIDS, Hepatitis B and C during blood transfusion should remain a major concern for the business.
Blood Preparation Market, By Product
Based on products, the industry is segmented into whole blood, components and derivatives. Whole blood segment dominated the industry contributing to the highest revenue share of over 48%, followed by derivatives with over 34% of global market share for 2015. Components will also manifest a decent forecast growth due to increasing use of packed red cells, leucocyte reduced RBCs, frozen plasma, platelet concentrate, cryoprecipitate and whole blood components.
Blood Preparation Market, By Application
Major industry applications include thrombocytosis, pulmonary embolism, renal impairment and angina blood vessel complications. Thrombocytosis and Pulmonary embolism (PE) are the leading causes of death, together attributing to over 43% of market size for 2015. Continuing clinical research studies in hematology and advent of novel therapeutic agents to treat patients and improve their quality of life will drive industry growth.
Blood Preparation Market, By Antithrombotic and Anticoagulant
Based on antithrombotic and anticoagulants, the industry is segmented into platelet aggregation inhibitors, fibrinolytics and anticoagulants. Anticoagulants led the overall industry with USD 17 billion in 2015, due to growing geriatric population base, increasing occurrence of thrombosis related disorders and increasing demand for rapid and more efficacious drugs. Increasing government initiatives in creating awareness related to the prevention of thrombosis disorders will expand the business consumer base.
Blood Preparation Market, By Region
U.S. will lead the industry due to increasing thrombocytosis disorder incidence, high patient awareness levels and presence of a robust healthcare infrastructure. FDA regulates collection, storage, and transport of blood and also works in collaboration with other agencies to implement health insurance for reimbursement for blood components.
Developed healthcare infrastructure across Germany and France and other EU nations will expand Europe market size.
China and India will experience robust industry growth owing to high number of blood-associated disorders, high unmet needs and various initiatives taken by governments. The positive growth of healthcare sector across Australia and Japan will also support regional share expansion.
Competitive Market Share
Major industry player comprises of Pfizer, GlaxoSmithKline, AstraZeneca, Leo Pharma, Celgene, Sanofi Aventis, Bristol-Myers, Baxter Healthcare, Shandong East Chemical.
Industry participants are investing heavily across R&D for novel, efficacious and cost efficient drugs for various blood related disorders. They are constantly engaged in developing new technologies and investing resources for the development of novel pipeline drugs to serve the demand of ever increasing patient population.
Blood Preparation Industry Background
Government organizations are taking initiatives for spreading awareness to prevent thrombosis-related complications by enabling diagnosis at early stage. As per CDC statistics, around 1-2 people per 1,000 suffer from DVT (Deep Vein thrombosis) or PE (Pulmonary embolism) each year in the U.S. Introduction of new oral anticoagulants and growing R&D programs by companies to develop robust antithrombotic and anticoagulant drug pipeline will fuel the market share. The industry has considerable growth opportunities with the development of high speed technology to separate blood components without losing their activity. Companies are introducing advanced types of instruments for easy and rapid preparation of blood components for e.g., Compomat G4 by Fresenius Kabi has the ability to separate large volumes of blood at higher speed. Growing demand for source plasma and need for specific blood components such as packed red blood cells will create untapped growth opportunities for the market.
What Information does this report contain?
Our Market Research Reports Include:
- Market snapshot
- Market Segmentation
- Value Chain Analysis
- Growth Dynamics
- Potential Market Opportunities
- Regulatory Overview
- Technology Evolution
- Innovation & Sustainability
Why Global Market Insights?Comprehensive Research
- All-inclusive coverage
- In-depth and granular data (ex: information for 8 to 15 countries, with clients open to add to this list, in each report)
- Penetrative insights & latest trends
- Offers holistic understanding of the market
- Unique methodology
- Iterative in nature to eliminate errors
- Detailed methodology, scope, assumptions and data sources available for reference
- Committed to making a positive difference for our clients
- Given the nature of this industry, we are committed to ensure that our clients get maximum return on their investment in our services
- Every purchase comes with an option to obtain additional information:
- up to 10% of the original cost
- 45-minute analyst tele-call to obtain further clarity on the market.
- Global Market Insights, Inc. strictly adheres to PCI-DSS security norms.
- Only PCI-DSS compliant payment methods used for highest level of client data security
Connect with our sales team